These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 32832719)

  • 1. Diabetes and dementia - the two faces of Janus.
    Papazafiropoulou AK; Koros C; Melidonis A; Antonopoulos S
    Arch Med Sci Atheroscler Dis; 2020; 5():e186-e197. PubMed ID: 32832719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus.
    Pelle MC; Zaffina I; Giofrè F; Pujia R; Arturi F
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-Like Peptide-1: A Focus on Neurodegenerative Diseases.
    Grieco M; Giorgi A; Gentile MC; d'Erme M; Morano S; Maras B; Filardi T
    Front Neurosci; 2019; 13():1112. PubMed ID: 31680842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
    Daulatzai MA
    J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?
    Biessels GJ; Kappelle LJ;
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1041-4. PubMed ID: 16246041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alzheimer's disease and diabetes - the common pathogenesis].
    Halmos T; Suba I
    Neuropsychopharmacol Hung; 2016 Mar; 18(1):5-19. PubMed ID: 27038867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiological Mechanisms Linking Type 2 Diabetes and Dementia: Review of Evidence from Clinical, Translational and Epidemiological Research.
    Bello-Chavolla OY; Antonio-Villa NE; Vargas-Vázquez A; Ávila-Funes JA; Aguilar-Salinas CA
    Curr Diabetes Rev; 2019; 15(6):456-470. PubMed ID: 30648514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Glucagon-Like Peptide 1 (GLP1) in Type 3 Diabetes: GLP-1 Controls Insulin Resistance, Neuroinflammation and Neurogenesis in the Brain.
    Bae CS; Song J
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Potential of Antidiabetic Agents as Therapeutic Approaches for Alzheimer's and Parkinson's Diseases: A Comprehensive Review.
    Koshatwar M; Acharya S; Prasad R; Lohakare T; Wanjari M; Taksande AB
    Cureus; 2023 Sep; 15(9):e44763. PubMed ID: 37809189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the metabolism of branched-chain amino acids in the development of Alzheimer's disease and other metabolic disorders.
    Polis B; Samson AO
    Neural Regen Res; 2020 Aug; 15(8):1460-1470. PubMed ID: 31997805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive disorder and dementia in type 2 diabetes mellitus.
    Ortiz GG; Huerta M; González-Usigli HA; Torres-Sánchez ED; Delgado-Lara DL; Pacheco-Moisés FP; Mireles-Ramírez MA; Torres-Mendoza BM; Moreno-Cih RI; Velázquez-Brizuela IE
    World J Diabetes; 2022 Apr; 13(4):319-337. PubMed ID: 35582669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Roles of Glucagon-Like Peptide-1 and Its Analogues in Dementia Targeting Impaired Insulin Secretion and Neurodegeneration.
    Mehan S; Bhalla S; Siddiqui EM; Sharma N; Shandilya A; Khan A
    Degener Neurol Neuromuscul Dis; 2022; 12():31-59. PubMed ID: 35300067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia.
    Abdelnour C; van Steenoven I; Londos E; Blanc F; Auestad B; Kramberger MG; Zetterberg H; Mollenhauer B; Boada M; Aarsland D;
    Mov Disord; 2016 Aug; 31(8):1203-8. PubMed ID: 27296778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis.
    Zhou JB; Tang X; Han M; Yang J; Simó R
    Metabolism; 2020 Aug; 109():154265. PubMed ID: 32446679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bariatric surgery may reduce the risk of Alzheimer's diseases through GLP-1 mediated neuroprotective effects.
    Keshava HB; Mowla A; Heinberg LJ; Schauer PR; Brethauer SA; Aminian A
    Med Hypotheses; 2017 Jul; 104():4-9. PubMed ID: 28673587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.
    Hölscher C
    Biochem Soc Trans; 2011 Aug; 39(4):891-7. PubMed ID: 21787319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer's Disease.
    Zhong KL; Chen F; Hong H; Ke X; Lv YG; Tang SS; Zhu YB
    Metab Brain Dis; 2018 Aug; 33(4):1009-1018. PubMed ID: 29626315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging links between type 2 diabetes and Alzheimer's disease.
    Sridhar GR; Lakshmi G; Nagamani G
    World J Diabetes; 2015 Jun; 6(5):744-51. PubMed ID: 26069723
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.